FDA To Investigate Bone Drugs' Effects On Heart

Law360, New York (October 2, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration said on Monday that it is investigating the possible risk of developing an irregular heart rhythm when taking a class of drugs known as bisphosphonates, which are used to treat bone diseases.

The FDA said in a public statement that is investigating whether the drugs, used to treat osteoporosis and to encourage bone regrowth in cancer patients, cause a type of cardiac arrhythmia known as atrial fibrillation. The condition is not fatal by itself but may cause discomfort and increase...
To view the full article, register now.